BioDrugs

期刊全称BioDrugs
期刊缩写BIODRUGS
涉及主题
(科研通AI识别)
医学生物内科学遗传学免疫学病理化学生物化学药理学外科心理学内分泌学精神科生物信息学疾病免疫系统抗体
期刊介绍

An essential resource for R&D professionals and clinicians with an interest in biologic therapies. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

期刊ISSNprint: 1173-8804
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
5.46.87.7445.8075.3134.9033.8252.835
历年发表/被引量
(科研通AI通过大数据分析)
年份20252024202320222021202020192018201720162015201420132012
发表量3458666051627265485235387167
被引量15033768373736463753313123682082192716931762170216291548
h-Index60
自引率5.60%
涉及的研究领域医学-免疫学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
2区2区 免疫学
2区肿瘤学
2区药学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
IMMUNOLOGYSCIEQ125/183
ONCOLOGYSCIEQ146/326
PHARMACOLOGY & PHARMACYSCIEQ124/352

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
IMMUNOLOGYSCIEQ135/183
ONCOLOGYSCIEQ165/326
PHARMACOLOGY & PHARMACYSCIEQ162/353
期刊主页https://www.springer.com/40259https://www.springer.com/journal/40259
投稿网址https://www.editorialmanager.com/bdra
出版商Springer International Publishing
出版国家(地区)NEW ZEALAND
出版语言English
出版周期Bimonthly
每年出版文章数47
Gold OA文章占比50.00%
原创研究文献占比
(排除综述)
58.18%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-8804%5BISSN%5D
平均审稿周期>12周,或约稿
平均录用比例较易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈